Medinice Past Earnings Performance
Past criteria checks 0/6
Medinice's earnings have been declining at an average annual rate of -23.7%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 15.5% per year.
Key information
-23.7%
Earnings growth rate
-12.0%
EPS growth rate
Medical Equipment Industry Growth | 25.3% |
Revenue growth rate | 15.5% |
Return on equity | -15.3% |
Net Margin | -2,254.2% |
Next Earnings Update | 28 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Medinice makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 0 | -5 | 5 | 0 |
30 Sep 23 | 0 | -6 | 5 | 0 |
30 Jun 23 | 0 | -6 | 5 | 0 |
31 Mar 23 | 0 | -5 | 5 | 0 |
31 Dec 22 | 0 | -5 | 4 | 0 |
30 Sep 22 | 0 | -4 | 4 | 0 |
30 Jun 22 | 0 | -3 | 4 | 0 |
31 Mar 22 | 0 | -3 | 4 | 0 |
31 Dec 21 | 0 | -3 | 3 | 0 |
30 Sep 21 | 0 | -4 | 3 | 0 |
30 Jun 21 | 0 | -4 | 3 | 0 |
31 Mar 21 | 0 | -3 | 2 | 0 |
31 Dec 20 | 0 | -3 | 2 | 0 |
30 Sep 20 | 0 | -3 | 3 | 0 |
30 Jun 20 | 0 | -3 | 3 | 0 |
31 Mar 20 | 0 | -3 | 2 | 0 |
31 Dec 19 | 0 | -2 | 2 | 0 |
30 Sep 19 | 0 | -2 | 0 | 0 |
30 Jun 19 | 0 | -1 | 1 | 0 |
31 Mar 19 | 0 | -2 | 1 | 0 |
31 Dec 18 | 0 | -2 | 1 | 0 |
30 Sep 18 | 0 | -1 | 1 | 0 |
31 Dec 17 | 0 | -1 | 1 | 0 |
Quality Earnings: ICE is currently unprofitable.
Growing Profit Margin: ICE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ICE is unprofitable, and losses have increased over the past 5 years at a rate of 23.7% per year.
Accelerating Growth: Unable to compare ICE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ICE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.2%).
Return on Equity
High ROE: ICE has a negative Return on Equity (-15.29%), as it is currently unprofitable.